developers

Andrew covers the biopharmaceutical industry, scientific research and public health across the continent. You can reach Andrew confidentially on Signal at drawqjoseph.71. Eli Lilly announced Tuesday that it would buy three early- and mid-stage vaccine developers, giving the field a boost. The deals — which together could cost nearly $4 billion — are the latest […]